Zdrowie i gospodarka · 21/11/2016
FDA Reopens Comment Period for Infant Formula Labeling Guidance
The Food and Drug Administration is reopening the comment period for its draft guidance on substantiation for structure/function claims made in infant formula labels and labeling, following a request for an extension from interested persons.